Effects of continuous positive airways pressure (CPAP) on portal flow in patients with obstructive apnoea syndrome (OSAS) Source: Eur Respir J 2007; 30: Suppl. 51, 321s Year: 2007
Continuous positive airway pressure (CPAP) among patients with cardiogenic pulmonary edema Source: Eur Respir J 2003; 22: Suppl. 45, 402s Year: 2003
Continuous positive airway pressure (CPAP) among patients with cardiogenic pulmonary edema Source: Eur Respir J 2003; 22: Suppl. 45, 72s Year: 2003
Continuous positive airway pressure (CPAP) treatment and systolic function in acute cardiogenic pulmonary edema (ACPE) Source: Eur Respir J 2006; 28: Suppl. 50, 820s Year: 2006
Noninvasive positive pressure ventilation (NPPV) in patients with chronic obstructive pulmonary disease (COPD): effect on the spontaneous PaCO2 and correlation between ventilator pressure and spontaneous PaCO2 Source: Eur Respir J 2001; 18: Suppl. 33, 401s Year: 2001
Influence of continuous positive airway pressure therapy on endothelial function and blood pressure in patients with arterial hypertension and obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006
Treatment of obstructive and restrictive lung disease with nasal intermittent positive pressure ventilation (NIPPV): influence on daytime gas exchange compared to controls Source: Eur Respir J 2001; 18: Suppl. 33, 403s Year: 2001
Continuous positive airway pressure (CPAP) in cardiogenic pulmonary oedema Source: Eur Respir J 2001; 18: Suppl. 33, 28s Year: 2001
Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006
A meta-analysis of nocturnal noninvasive positive pressure ventilation (NIPPV) in stable patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 402s Year: 2001
Efficacy of continous positive airway pressure (CPAP) in the treatment of the obesity hypoventilation syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 726s Year: 2005
Effects of different levels of nasal continuous positive airways pressure (CPAP) in infants with severe acute bronchiolitis Source: Eur Respir J 2006; 28: Suppl. 50, 264s Year: 2006
Noninvasive positive pressure ventilation (NPPV) for the treatment of acute exacerbation of chronic obtructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 280s Year: 2002
Predictors of continuous positive airway pressure (CPAP) response in severe hypoxaemic respiratory failure due to COVID-19 pneumonitis Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021
Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010
Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure Source: Eur Respir J, 57 (2) 2002524; 10.1183/13993003.02524-2020 Year: 2021
Continuous positive airway pressure treatment in patients with OSA Source: Eur Respir Mon 2010; 50: 244-266 Year: 2010
Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients Source: Eur Respir J 2006; 27: 1229-1235 Year: 2006
Lung perfusion and ventilation modifications induced by nasal non-invasive positive pressure ventilation (nNPPV) in patients with CRF due to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 625s Year: 2002
Are there any patient-features to predict long-term benefit from noninvasive intermittent positive pressure ventilation (nIPPV) in patients with severe stable chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 403s Year: 2001